Leland Metheny, MD
Enriched profileAssistant Professor, University Hospitals · University Hospitals
Leland Metheny is Assistant Professor, University Hospitals at University Hospitals. OpenAlex indexes 173 publications with 1,694 citations (h-index 20); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 24 Oct 2026
Overview
Updated 28 Oct 2026
Leland Metheny, M.D., is Assistant Professor, University Hospitals. The public record shows 173 publications with 1,694 citations (h-index 20), centered on Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, CAR-T cell therapy research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 10 companies, 1 NIH-funded awards (2021–2024).
- Most recent indexed publication: 2025 · Bone marrow transplantation
- Top research focus: Hematopoietic Stem Cell Transplantation
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 30.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Sponsor: Case Comprehensive Cancer Center
- ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Sponsor: Leland Metheny
- LMY-920 for Treatment of Relapsed or Refractory Myeloma
Sponsor: Luminary Therapeutics
Industry payments
Updated 28 Oct 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Janssen Biotech, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
56.4%Kinase inhibitor33.1%Imbruvica49%Calquence43%Jakafi9%Part D<11 patientsAntimetabolite10.5%Hydroxyurea100%Part D≥14 patients+ 2 more classes in this area
Dermatology
13.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor13.7%Acyclovir100%Part D≥29 patientsNervous system
8.5%Phenothiazine3.9%Prochlorperazine Maleate100%Part D≥15 patientsGabapentinoids2.5%Gabapentin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 28 Oct 2026
1 NIH research award on record, funded 2021–2024 per NIH RePORTER. The latest:
Congress activity
Updated 28 Oct 2026
55 congress contributions (2017–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Abstract 1543: B-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndrome
AACR Annual Meeting
AACR2026Co-author - Avoidance of ATG improves outcomes in double-cord blood transplantation for hematological malignancies
ASH Annual Meeting
ASH2025Presenting author - CD34 selected stem cell boost provides robust outcomes in patients with poor graft function
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.
Bone marrow transplantation
Erratum2025 - Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.
Bone marrow transplantation
Clinical Trial2023
Most-cited works
by citation count (OpenAlex)- 01Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyArticle277 citations2018
- 02Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyArticle262 citations2020
- 03Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyArticle140 citations2024
- 04
- 05NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017Article83 citations2016
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
case.edu/cancer/members/member-directory/leland-metheny
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →case.edu ↗ - Other
uhhospitals.org/find-a-doctor/metheny-leland-16006
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uhhospitals.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →case.edu ↗
Secondary affiliations
appointments beyond the home institution- Case Western Reserve University School of Medicine
Department of Medicine (Assistant Professor)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →case.edu ↗ - Case Comprehensive Cancer Center
Immune Oncology Program (Member)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →case.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
S Rajkumar, MD
Mayo Clinic
Meletios Dimopoulos, MD
National and Kapodistrian University of Athens